Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Pathology
Nikki Cheng has not added Biography.
If you are Nikki Cheng and would like to personalize this page please email our Author Liaison for assistance.
The ephrins and Eph receptors in angiogenesis.
Cytokine & growth factor reviews Feb, 2002 | Pubmed ID: 11750881
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
Oncogene Oct, 2002 | Pubmed ID: 12370823
Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Molecular cancer research : MCR Nov, 2002 | Pubmed ID: 12496364
Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.
Neoplasia (New York, N.Y.) Sep-Oct, 2003 | Pubmed ID: 14670182
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
Oncogene Jul, 2005 | Pubmed ID: 15856015
Genomic and proteomic analysis of mammary tumors arising in transgenic mice.
Journal of proteome research Nov-Dec, 2005 | Pubmed ID: 16335954
Inhibition of retinal neovascularization by soluble EphA2 receptor.
Experimental eye research Apr, 2006 | Pubmed ID: 16359662
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cancer research May, 2007 | Pubmed ID: 17495323
Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.
Cancer biology & therapy Apr, 2007 | Pubmed ID: 17495520
Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1.
Journal of cellular biochemistry Oct, 2008 | Pubmed ID: 18729074
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Molecular cancer research : MCR Oct, 2008 | Pubmed ID: 18922968
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
The Journal of clinical investigation Jun, 2009 | Pubmed ID: 19451693
Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.
Proteomics Jul, 2010 | Pubmed ID: 20405477
Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.
Neoplasia (New York, N.Y.) May, 2010 | Pubmed ID: 20454514
Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.
Cancer therapy Apr, 2009 | Pubmed ID: 20651940
Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
Clinical & experimental metastasis Apr, 2011 | Pubmed ID: 21374085
University of Kansas Medical Center
Nikki Cheng1,
Diana L. Lambert1
1Department of Pathology, University of Kansas Medical Center
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados